Second HMA/EMA multi-stakeholder forum on EudraVigilance and signal detection, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 December 2026, 09:00 (CET) to 1 December 2026, 17:30 (CET)

First European Medicines Agency (EMA) - International Society for Cell and Gene Therapy (ISCT) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 October 2026, 15:30 (CEST) to 5 October 2026, 17:30 (CEST)

PSUSA/00002550/202601

Human medicines European public assessment report (EPAR): Orgovyx, relugolix, Date of authorisation: 29/04/2022, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Ziextenzo, pegfilgrastim, Date of authorisation: 22/11/2018, Revision: 11, Status: Authorised

Regulatory sandboxes: Joint European Commission (EC) / European Medicines Agency (EMA) multi-stakeholder workshop, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 21 September 2026, 13:30 (CEST) to 21 September 2026, 17:00 (CEST)

Human medicines European public assessment report (EPAR): Arsenic trioxide Accord, arsenic trioxide, Date of authorisation: 14/11/2019, Revision: 9, Status: Authorised

EMA/PE/0000302950

Human medicines European public assessment report (EPAR): Rasilez, aliskiren, Date of authorisation: 22/08/2007, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised